Bieniasz, Paul D.
Rockefeller University,
United States
2025 Rank: 10077
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 60 out of 75944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10077 | 10913 |
| Total Cites | 28560 | 31098 |
| H-index | 84 | 88 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 973 | 1007 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 2067 | 2196 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 15090 | 16288 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 18450 | 19257 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.61 |
| Self-Citation Percentage |
8.16%
|
|
Bieniasz, Paul D.
Howard Hughes Medical Institute,
United States
2024 Rank: 9697
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 58 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9697 | 10636 |
| Total Cites | 26562 | 28985 |
| H-index | 82 | 86 |
| Hm-index | 29 | 30 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 946 | 980 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 2018 | 2148 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 14394 | 15571 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 17000 | 17762 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.63 |
| Self-Citation Percentage |
8.36%
|
|
Bieniasz, Paul D.
Rockefeller University,
United States
2023 Rank: 9571
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 61 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9571 | 10283 |
| Total Cites | 23913 | 26160 |
| H-index | 80 | 84 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 926 | 959 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1977 | 2105 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 13528 | 14651 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15048 | 15753 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.66 |
| Self-Citation Percentage |
8.59%
|
|
Bieniasz, Paul D.
Rockefeller University,
United States
2022 Rank: 9952
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Developmental Biology
Rank in SubField 1: 65 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9952 | 10809 |
| Total Cites | 19611 | 21615 |
| H-index | 74 | 77 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 901 | 934 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1928 | 2055 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 12057 | 13106 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12017 | 12656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.71 |
| Self-Citation Percentage |
9.27%
|
|
Bieniasz, Paul D.
Rockefeller University,
United States
2021 Rank: 10446
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Developmental Biology
Rank in SubField 1: 68 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10446 | 11137 |
| Total Cites | 17390 | 19247 |
| H-index | 70 | 73 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 884 | 917 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1889 | 2014 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 11353 | 12352 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 10514 | 11117 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.73 |
| Self-Citation Percentage |
9.65%
|
|
Bieniasz, Paul D.
Rockefeller University,
United States
2020 Rank: 10711
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Developmental Biology
Rank in SubField 1: 85 out of 58416 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10711 | 11521 |
| Total Cites | 15119 | 16797 |
| H-index | 64 | 67 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 848 | 881 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1818 | 1940 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 10298 | 11230 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 8874 | 9408 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.79 |
| Self-Citation Percentage |
9.99%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.